A 36-year-old woman presented with a 6-year history of gradually worsening low back pain and intermittent night sweats. On examination, she had a sharp, kyphotic angulation of the lower spine.

New Medicaid eligibility rules will burden both beneficiaries and physicians, threaten funding for health care institutions and clinicians, and leave more U.S. residents without insurance coverage.

Explore the current issue of The New England Journal of Medicine (Vol. 395 No. 15).

A 39-year-old man, who was an Iraq War veteran with exposure to burn pits, was admitted to the hospital with hypertension, ...

Continuous glucose monitoring (CGM) has been shown to be beneficial in persons with type 1 diabetes and others with insulin-treated type 2 diabetes, but its role in the treatment of persons with type ...

Interview with Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients. 13m 49s Download According to the age-friendly health care model, every health ...

The World Health Organization recently issued its first global guidelines on the prevention, diagnosis, and treatment of infertility, but they pertain only to heterosexual couples.

A 19-year-old woman presented with fever and cervical lymphadenopathy. The white-cell count was 2900 per microliter (reference range, 4000 to 11,000), and the lactate dehydrogenase level was ...

The author describes the science behind a study of intravitreal delivery of an AAV vector encoding a light-gated ion channel in 10 blind patients with advanced retinitis pigmentosa.

When public health measures conflict with cultural, relational, and emotional practices surrounding severe illness and death, they may lead to uprisings that increase the risk of infection spread.

The efficacy and popularity of GLP-1 agents have sparked a race to develop increasingly potent therapies. But protections for people enrolled in trials of investigational products may be inadequate.

Settlements of lawsuits against opioid manufacturers and other entities will shape drug policy for decades. Attention is needed to ensure that the funds will be dedicated to evidence-based activities.